• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG PROGAV 2.0 SYS SA2.0 20 & CONTROL RES.; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG PROGAV 2.0 SYS SA2.0 20 & CONTROL RES.; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX602T
Medical Device Problem Code Mechanical Problem (1384)
Health Effect - Clinical Code Hydrocephalus (3272)
Date of Event 11/08/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Visual inspection: during the investigation, no significant deformations or damage of the valve were determined.Permeability test: a permeability test has shown that all components have a blockage.Computer controlled test: because the valve is not permeable, a computer controlled test is not possible.Adjustment test: the progav 2.0 was tested and is not adjustable.Braking force and brake function test: the brake functionality test has shown that the brake function operates as expected; however, the breaking force cannot be measured due to the non-adjustability of the valve.Internal inspection: after dismantling of the valves, deposits were found in both valves.Results: in advance, we would like to point out that the product sent in was not inserted in liquid at the time of delivery.Dried deposits can influence the function of the products, which can affect the results.Despite this, we have examined the shunt system.Based on our investigation results, we can determine an occlusion of both valves and a non-adjustability of the progav 2.0.The visible deposits in the valves have led to the functional impairment.Deposits caused by substances naturally present in the patient's body, such as organic matter, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Even small amounts of organic material can affect the integrity of the valve.An examination of the detachment of the reservoir from the catheter revealed a damage of the catheter and the kink protection.Retrospectively, we are not able to determine how this damage occurred.Severe pulling or bending of the connection during surgery or high tensile forces can cause such damage or even rupture of the connection.Based on the fact that the shunt system had been implanted for 4 years and all catheters at miethke are cut by machine with a straight cut, we can rule out a defect at the time of delivery.Based on the traceability the shunt system met all quality control specifications at the time of release.
 
Event or Problem Description
It was reported that a progav 2.0 shuntsystem (#fx602t) was implanted during a procedure.According to the complainant, the shunt system had adjustment difficulties.The patient underwent a revision procedure.No patient complications were reported as a result of the revision procedure.The complainant device was returned to the manufacturer for evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV 2.0 SYS SA2.0 20 & CONTROL RES.
Common Device Name
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key20847359
Report Number3004721439-2024-00374
Device Sequence Number17103502
Product Code JXG
UDI-Device Identifier04041906503222
UDI-Public4041906503222
Combination Product (Y/N)N
Initial Reporter CountryBE
PMA/510(K) Number
K190174
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 12/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/18/2025
Device Model NumberFX602T
Device Catalogue NumberFX602T
Device Lot Number20048438
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/15/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/08/2024
Initial Report FDA Received Date12/04/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/19/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-